Their potential role in cognitive impairment is increasingly recognized: higher circulating EMP concentrations have been observed in patients with mild cognitive impairment and Alzheimer’s disease, suggesting a mechanistic link between systemic endothelial activation and cerebral amyloid deposition and tau pathology [31]. The gene discussed is MAPT; the disease is Alzheimer disease.